Advanced Search
Contact | Corporate | Help

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Sponsors:
  • Merck KGaA
  • Merck Serono Middle East FZ LLC, an affiliate of Merck KGaA, Darmstadt, Germany
Phases:
  • Phase III
IndicationsAcronym:
  • Infertility
  • Fertility
  • Follicle Stimulating Hormone Deficiency
Age Groups:
  • Adult
Gender:
Female
Names:
  • Drug: Lutropin alfa
  • Drug: Lutropin alpha
Enrollment:
208

Additional information about NCT01497197.


SourceSolution © 2008-2012